Prognosis and survival for fallopian tube cancer

If you have fallopian tube cancer, you may have questions about your prognosis. A prognosis is the doctor’s best estimate of how cancer will affect someone and how it will respond to treatment. Prognosis and survival depend on many factors. Only a doctor familiar with your medical history, the type and stage and other features of your cancer, the treatments chosen and the response to treatment can put all of this information together with survival statistics to arrive at a prognosis.

A prognostic factor is an aspect of the cancer or a characteristic of the person (such as whether they smoke) that the doctor will consider when making a prognosis. A predictive factor influences how a cancer will respond to a certain treatment. Prognostic and predictive factors are often discussed together. They both play a part in deciding on a treatment plan and a prognosis.

The following are prognostic and predictive factors for fallopian tube cancer.


The stage of the cancer is the most important prognostic factor for fallopian tube cancer. Women diagnosed with early stage fallopian tube cancer have a better prognosis than women diagnosed with cancer at a later stage.

Cancer cells in ascites or peritoneal washings

If cancer cells are found in fluid that has built up in the abdomen (called ascites) or the washings of the peritoneum taken during surgery, the prognosis is poorer.

Tumour type

Some types of fallopian tube cancer have a better prognosis. The characteristics of a particular type of tumour often relate to the grade or stage of the tumour.


The grade of the cancer is an important prognostic factor for fallopian tube cancer. Low-grade tumours are associated with a better prognosis than high-grade tumours.

Cancer that remains after surgery

The amount of cancer that remains after surgery is called residual disease. Women who have no residual disease have a better prognosis than women who have cancer remaining after surgery.


Younger women who have fallopian tube cancer have a better prognosis than older women.

Expert review and references

  • American Society of Clinical Oncology. Ovarian, Fallopian Tube, and Peritoneal Cancer. 2016:
  • Black D, Barakat RR . Fallopian tube cancer. Raghavan D, Blanke CD, Honson DH, et al (eds.). Textbook of Uncommon Cancer. 4th ed. Wiley Blackwell; 2012: 38: 531 - 539.
  • Cannistra SA, Gershenson DM, Recht A . Ovarian cancer, fallopian tube carcinoma, and peritoneal carcinoma. DeVita VT Jr, Lawrence TS, Rosenberg SA. Cancer: Principles and Practice of Oncology. 10th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2015: 76: 1075-1099.
  • Levine DA, Dizon DS, Yashar CM, Barakat RR, Berchuch A, Markman M, Randall ME. Handbook for Principles and Practice of Gynecologic Oncology. 2nd ed. Philadelphia, PA: Wolters Kluwer; 2015.

Survival statistics for fallopian tube cancer

Survival statistics for Fallopian tube cancer are very general estimates and must be interpreted very carefully. Because these statistics are based on the experience of groups of people, they cannot be used to predict a particular person’s chances of survival.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on, nor do we endorse any service, product, treatment or therapy.

1-888-939-3333 | | © 2024 Canadian Cancer Society